Farthing C et al. |
Azithromycin for cerebral toxoplasmosis. |
1992 |
Lancet |
pmid:1346707
|
Chave JP et al. |
Once-a-week azithromycin in AIDS patients: tolerability, kinetics, and effects on zidovudine disposition. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324635
|
Derouin F et al. |
Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324642
|
Vallée E et al. |
Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324644
|
Mertens JC et al. |
Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324645
|
Hammerschlag MR et al. |
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324650
|
Paulsen P et al. |
Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome. |
1992 |
Chemotherapy |
pmid:1324831
|
Pajukanta R et al. |
In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329617
|
Bonnet M and Van der Auwera P |
In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329619
|
Neu HC |
New macrolide antibiotics: azithromycin and clarithromycin. |
1992 |
Ann. Intern. Med. |
pmid:1310839
|
Massarotti EM et al. |
Treatment of early Lyme disease. |
1992 |
Am. J. Med. |
pmid:1313637
|
Pruul H and McDonald PJ |
Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1317141
|
Brown BA et al. |
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1317144
|
Kobrehel G et al. |
Synthesis and antibacterial activity of O-methylazithromycin derivatives. |
1992 |
J. Antibiot. |
pmid:1317368
|
Welsh LE et al. |
In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1318677
|
Bahal N and Nahata MC |
The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. |
1992 |
Ann Pharmacother |
pmid:1318761
|
Drew RH and Gallis HA |
Azithromycin--spectrum of activity, pharmacokinetics, and clinical applications. |
1992 |
Pharmacotherapy |
pmid:1319048
|
Felstead SJ and Daniel R |
Short-course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group. |
1991 Sep-Oct |
J. Int. Med. Res. |
pmid:1660823
|
Daniel R |
Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group. |
1991 Sep-Oct |
J. Int. Med. Res. |
pmid:1660824
|
Kimata I et al. |
Chemotherapeutic effect of azithromycin and lasalocid on Cryptosporidium infection in mice. |
1991 Nov-Dec |
J. Protozool. |
pmid:1667931
|